We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Frontier Ip Group Plc | LSE:FIPP | London | Ordinary Share | GB00B63PS212 | ORD 10P |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 43.50 | 42.00 | 45.00 | 43.50 | 43.50 | 43.50 | 84,703 | 07:33:18 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Real Estate Agents & Mgrs | 372k | -3.24M | -0.0580 | -7.50 | 24.32M |
TIDMFIPP
Frontier IP Group plc
05 July 2017
RNS REACH
AIM: FIPP
5 July 2017
Frontier IP Group Plc
("Frontier IP" or the "Group")
New Portfolio Company - MolEndoTech
Frontier IP, which specialises in the commercialisation of intellectual property, is pleased to announce that it has received a 20 per cent. stake in Molendotech Limited ("MolEndoTech"), a spinout company from Plymouth University.
MolEndoTech has been created to develop and commercialise the work of Simon Jackson, Professor of Environment and Human Health within the Plymouth University, Peninsula Schools of Medicine and Dentistry.
The MolEndoTech team has developed a rapid assay to screen water for faecal contamination. Current tests on the market may take hours or even days to show results, whereas MolEndoTech's technology typically produces results in under 15 minutes. Rapid, point-of-use testing to determine water quality enables more informed decision-making about the use of water and significantly improves the ability to identify and track the pollution source.
A patent has been filed in relation to the technology which has already been granted in the US for recreational waters. The technology has attracted early interest from industry.
Neil Crabb, CEO, Frontier IP Group plc said:
"We are looking forward to working with Professor Jackson and his team to help accelerate the commercialisation for this promising technology. We believe that MolEndoTech has an exciting future in the critical area of water quality assurance and are pleased to see the technology is already generating interest in the marketplace."
Professor Simon Jackson, Director of MolEndoTech, said:
"This is a great opportunity to take MolEndoTech's technology to market. Frontier IP has an excellent track record of commercialising technology and we will be working closely with them to commercialise our innovation."
Enquiries
Frontier IP Group Plc T: 0131 240 1251 Neil Crabb, Chief Executive Company website: www.frontierip.co.uk Cenkos Securities plc (Nominated T: 0131 220 6939 Adviser and Joint Broker) Neil McDonald / Beth McKiernan Peterhouse Corporate Finance T: 020 7469 0935 Limited (Joint Broker) Lucy Williams Kreab (Financial PR) T: 020 7074 1800 Robert Speed / Matthew Jervois
Notes to Editor:
Frontier IP Group plc
www.frontierip.co.uk.
Frontier IP specialises in assisting institutions and companies in the commercialisation and exploitation of their intellectual property. It establishes formal and informal relationships with sources of exploitable IP, principally universities. Its core business is building and growing a portfolio of equity stakes in spin--out companies by taking an active involvement in the commercialisation and funding of these businesses.
This information is provided by RNS
The company news service from the London Stock Exchange
END
NRAOKQDNQBKDFOK
(END) Dow Jones Newswires
July 05, 2017 02:00 ET (06:00 GMT)
1 Year Frontier Ip Chart |
1 Month Frontier Ip Chart |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions